Tanacetum parthenium: differenze tra le versioni
Contenuto cancellato Contenuto aggiunto
Riga 78:
* Kishida Y et al. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells. Clin Cancer Res. 2007; 13(1):59-67.
* Zhou HQ, Zhang FC, Rk W. Parthenolide inhibits tumor necrosis factor-alpha induced catabolism of aggrecan in chondrocytes in osteoarthritis: in vitro experiment with cultured human chondrocytes.Zhonghua Yi Xue Za Zhi. 2008 Mar 18; 88(11):764-68.
* Pajak B et al. Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells. Folia Histochem Cytobiol. 2008; 46
* Neelakantan S et al. Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1). Bioorg Med Chem Lett. 2009; 19(15):4346-49.
* Liu Z et al. Modulation of DNA methylation by a sesquiterpene lactone parthenolide. J Pharmacol Exp Ther. 2009; 329(2):505-14.
* Oka D, Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB. Int J Cancer. 2007; 120(12):2576-81.
* Zhao LJ
* Zhang D et al. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo. Mol Cancer Res. 2009; 7(7):1139-49.
* Fang LJ et al. Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis. Planta Med. 2010; 76(3):258-64.
| |||